Foghorn Therapeutics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $271.5M | $271.3M | $247.0K | $3.2M |
| Jun 2022 | $-29.0M | $-29.4M | $364.0K | $3.5M |
| Sep 2022 | $-20.0M | $-20.3M | $330.0K | $3.8M |
| Dec 2022 | $-28.9M | $-29.2M | $269.0K | $3.8M |
| Mar 2023 | $-31.2M | $-31.8M | $636.0K | $4.6M |
| Jun 2023 | $-32.2M | $-32.6M | $469.0K | $4.5M |
| Sep 2023 | $-27.2M | $-27.3M | $82.0K | $4.1M |
| Dec 2023 | $-27.5M | $-27.6M | $37.0K | $3.1M |
| Mar 2024 | $-29.3M | $-29.4M | $101.0K | $3.2M |
| Jun 2024 | $-25.5M | $-25.6M | $17.0K | $3.2M |
| Sep 2024 | $-21.0M | $-21.3M | $309.0K | $3.0M |
| Dec 2024 | $-24.5M | $-25.0M | $479.0K | $2.5M |
| Mar 2025 | $-24.0M | $-24.0M | $28.0K | $2.7M |
| Jun 2025 | $-21.0M | $-21.0M | $22.0K | $2.7M |
| Sep 2025 | $-18.9M | $-18.9M | $0 | $2.7M |
| Dec 2025 | $-22.3M | $-22.3M | $0 | $2.2M |
| Mar 2026 | $-25.3M | $-25.3M | $0 | $2.4M |
| Jun 2026 | $-17.8M | $-17.9M | $50.0K | $2.6M |